4//SEC Filing
Schiller Mark C. 4
Accession 0001415889-24-020202
CIK 0001645666other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 5:41 PM ET
Size
5.2 KB
Accession
0001415889-24-020202
Insider Transaction Report
Form 4
Schiller Mark C.
Chief Legal Officer
Transactions
- Sale
Common Stock
2024-07-02$0.58/sh−6,688$3,879→ 33,007 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0002007659
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 5:41 PM ET
- Size
- 5.2 KB